Atlas Trials

A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell Neoplasms

Clinical trial NCT07200479 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07200479
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed/Refractory B-Cell Neoplasms
Start date
2025-10-30
Primary completion
2027-06-28
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.